NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
0.610
-0.027 (-4.24%)
At close: Nov 20, 2024, 4:00 PM
0.595
-0.015 (-2.39%)
After-hours: Nov 20, 2024, 5:28 PM EST
NanoVibronix Employees
As of December 31, 2023, NanoVibronix had 16 total employees, including 10 full-time and 6 part-time employees. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
$205,688
Profits / Employee
-$192,938
Market Cap
2.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Xylo Technologies | 84 |
Scorpius Holdings | 84 |
Avinger | 72 |
Biodexa Pharmaceuticals | 21 |
HeartSciences | 15 |
Phio Pharmaceuticals | 9 |
PainReform | 7 |
NAOV News
- 9 days ago - NanoVibronix Provides Business Update - Business Wire
- 6 weeks ago - NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - Business Wire
- 2 months ago - NanoVibronix Signs Letter of Intent with Potential New Distributor - Business Wire
- 3 months ago - NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - Business Wire
- 6 months ago - NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan - Business Wire
- 6 months ago - NanoVibronix Issues Letter to Stockholders - Business Wire
- 6 months ago - NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield - Business Wire
- 7 months ago - NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award - Business Wire